NCT00075894View on ClinicalTrials.gov

Alanosine in Treating Patients With Progressive or Recurrent Malignant Gliomas

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

March 31, 2004

Conditions
Brain and Central Nervous System Tumors
Interventions
DRUG

L-alanosine

Trial Locations (5)

48202

Josephine Ford Cancer Center at Henry Ford Hospital, Detroit

33612-9497

H. Lee Moffitt Cancer Center and Research Institute at University of South Florida, Tampa

21231-2410

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

02114

Massachusetts General Hospital Cancer Center, Boston

27157-1096

Wake Forest University Comprehensive Cancer Center, Winston-Salem

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00075894 - Alanosine in Treating Patients With Progressive or Recurrent Malignant Gliomas | Biotech Hunter | Biotech Hunter